Figure 5: Denosumab inhibits calcification of VICs. Showing (A) Alizarin Red staining for calcium deposition, and (B) quantification of calcium deposition: a denotes P < 0.001 when compared to the medium only control; b and c denote P < 0.001 when compared to cells not treated with Denosumab.